期刊文献+

临床药师参与肾移植术后合并急性心肌梗死患者的药学监护 被引量:2

Clinical pharmacists participate in the pharmaceutical care of patients with acute myocardial infarction after renal transplantation
下载PDF
导出
摘要 目的 :探讨临床药师对特殊生理或病理状态患者的药学监护方法,为临床合理用药提供参考。方法 :对1例肾移植术后4年发生急性非ST段抬高型心肌梗死患者从药物选择、相互作用、代谢、排泄等方面进行全程的药学监护,为医师的药物治疗提供合理化用药建议。结果 :通过药师积极参与下的药学监护,患者好转出院。结论 :临床药师参与临床药物治疗过程,为患者制定个体化的药物治疗和监护方案,可以有效保障患者用药安全,提高个体化用药水平。 Objective: To explore the clinical pharmaceutical care methods for patients with special physiological or pathological conditions so as to provide reference for clinical rational use of drugs. Methods: The clinical pharmacist offered the entire pharmaceutical care including drug selection, interaction, metabolism, excretion to the patients who suffered from acute non-s-segment elevation myocardial infarction with 4 years kidney transplantation and provided recommendations of the rational drug use for the physician medication. Results: The patient safely discharged from hospital by pharmaceutical care under the active participation of the pharmacists. Conclusion: The safety of patients' medication can be effectively guaranteed and the level of individualized medication can be improved by clinical pharmacists participating in clinical drug treatment processes and developing individualized medication and pharmaceutical care for patients.
作者 申瑞 毛敏 SHEN Rui;MAO gin(Department of Clinical Pharmacy,the People's Hospital of Wuhai City,Inner Mongolia Wuhai 016000,China;Department of Pharmacy,China-Japan Friendship Hospital,Beijing 100029,China)
出处 《上海医药》 CAS 2018年第21期72-74,78,共4页 Shanghai Medical & Pharmaceutical Journal
关键词 临床药师 急性心肌梗死 肾移植术后 药学监护 clinical pharmacist acute myocardial infarction kidney transplant pharmaceutical care
  • 相关文献

参考文献1

二级参考文献20

  • 1Müller I, Besta F, Schulz C, et al. Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation, 2003, 108: 2195-2197.
  • 2Gorchakova O, von Beckerath N, Gawaz M, et al. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. Eur Heart J, 2004, 25: 1898-1902.
  • 3von Beckerath N, Gorchakova O, Motz A, et al. Full antiplatelet effect of a loading dose clopidogrel in the presence of statin therapy. Circulation, 2003, 108(suppl): IV-160.
  • 4Serebruany VL, Malinin AI, Callahan KP, et al. Statins do not affect platelet inhibition with clopidogrel during coronary stenting. Atherosclerosis, 2001, 159: 239-241.
  • 5Smith SM, Judge HM, Peters G, et al. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention. Platelets, 2004, 15: 465-474.
  • 6Saucedo JF, Aude W, Garza L. Statin therapy with atorvastatin or simvastatin does not decrease the antiplatelet effect of clopidogrel or eptifibatide during percutaneous intervention. Circulation, 2003, 108(suppl): 575-579.
  • 7Serebruany VL, Midei MG, Malinin AI, et al. Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. Arch Intern Med, 2004, 164: 2051-2057.
  • 8Serebruany VL, Steinhubl SR, Hennekens CH. Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested. Circulation, 2003, 107: 1568-1569.
  • 9Wienbergen H, Gitt AK, Schiele R, et al. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. Am J Cardiol, 2003, 92: 285-288.
  • 10Saw J, Steinhubl SR, Berger PB, et al. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation, 2003, 108: 921-924.

共引文献14

同被引文献28

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部